| Mrs Dana Swanson, MS | |
|
2795 Pilot Knob Rd Ste 100, Eagan, MN 55121-1930 | |
| (651) 994-9644 | |
| (651) 994-8962 |
| Full Name | Mrs Dana Swanson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2795 Pilot Knob Rd Ste 100, Eagan, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235655184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 9939 (Minnesota) | Primary |
| Provider Name | Childrens Therapy Center Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1295809366 PECOS PAC ID: 8426358854 Enrollment ID: O20151207003001 |
News Archive
"Johnson & Johnson [J&J] said Monday that it is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis [TB] in more than four decades," the Associated Press reports, adding, "The experimental drug, called bedaquiline, also would be the first medicine specifically for treating multi-drug resistant tuberculosis."
Titan Pharmaceuticals, Inc. today announced that it has entered into a Loan and Security Agreement with Oxford Finance Corporation ("Oxford") for a $3 million term loan. The loan will bear interest at an approximate rate of 13% per annum and be payable over three years. Under the terms of the agreement, Titan will pay Oxford an initial facility fee of $60,000 and a final payment fee of $180,000.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers in the Abramson Cancer Center of the University of Pennsylvania published in JCI Insight.
The study by The Cancer Genome Atlas (TCGA) researchers analyzed the genomes of 279 head and neck cancer tumors. They identified subtypes of head and neck cancer based on their genomic characteristics, changes in smoking-related tumors, as well as genomic differences in head and neck cancer tumors linked to HPV, the most commonly sexually transmitted disease in the United States.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dana Swanson, MS 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121-1930 Ph: (651) 994-9644 | Mrs Dana Swanson, MS 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121-1930 Ph: (651) 994-9644 |
News Archive
"Johnson & Johnson [J&J] said Monday that it is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis [TB] in more than four decades," the Associated Press reports, adding, "The experimental drug, called bedaquiline, also would be the first medicine specifically for treating multi-drug resistant tuberculosis."
Titan Pharmaceuticals, Inc. today announced that it has entered into a Loan and Security Agreement with Oxford Finance Corporation ("Oxford") for a $3 million term loan. The loan will bear interest at an approximate rate of 13% per annum and be payable over three years. Under the terms of the agreement, Titan will pay Oxford an initial facility fee of $60,000 and a final payment fee of $180,000.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers in the Abramson Cancer Center of the University of Pennsylvania published in JCI Insight.
The study by The Cancer Genome Atlas (TCGA) researchers analyzed the genomes of 279 head and neck cancer tumors. They identified subtypes of head and neck cancer based on their genomic characteristics, changes in smoking-related tumors, as well as genomic differences in head and neck cancer tumors linked to HPV, the most commonly sexually transmitted disease in the United States.
› Verified 6 days ago
Shirin Razavian, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2030 Rahn Way, Eagan, MN 55122 Phone: 651-529-1960 | |
Claudia Christensen-major, MACCCSLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2795 Pilot Knob Rd, Suite 100, Eagan, MN 55121 Phone: 651-994-9644 Fax: 651-994-8962 | |
Kelly Carlson, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Suite 100, Eagan, MN 55121 Phone: 651-994-9644 Fax: 651-994-8962 | |
Jennifer Bailey, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Suite #100, Eagan, MN 55121 Phone: 651-994-9644 Fax: 651-994-8962 | |
Katlyn Elizabeth Dahlstrom, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3305 Central Park Village Dr Ste 130, Eagan, MN 55121 Phone: 651-406-8868 | |
Amanda Enstrom, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3464 Washington Dr, Suite 110, Eagan, MN 55122 Phone: 952-460-4278 | |
Kelsey Falligant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121 Phone: 651-994-9644 |